Madelynn N. Whittaker

Also affiliated with University of Pennsylvania

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “High-fidelity PAMless base editing of hematopoietic stem cells to treat chronic granulomatous disease”.

High-fidelity PAMless base editing of hematopoietic stem cells to treat chronic granulomatous disease

Science Translational Medicine(2024)10.1126/scitranslmed.adj6779

N/A

0.585DataRank · unranked

23 citations

Linyuan Ma, Siyuan Liu, Lauren R. Fox, Madelynn N. Whittaker, Ronald J. Meis +15 more

Efficient in vivo prime editing corrects the most frequent phenylketonuria variant, associated with high unmet medical need

The American Journal of Human Genetics(2023)10.1016/j.ajhg.2023.10.005

N/A

0.561DataRank · unranked

41 citations

Madelynn N. Whittaker, Ping Qü, Kiran Musunuru, Rebecca C. Ahrens‐Nicklas, Xiao Wang +1 more

Allele-specific silencing of the gain-of-function mutation in Huntington’s disease using CRISPR/Cas9

JCI Insight(2022)10.1172/jci.insight.141042

N/A

0.533DataRank · unranked

34 citations

Eun Pyo Hong, Seri S. Park, Doo Eun Choi, Ihn Sik Seong, Madelynn N. Whittaker +4 more

Improved specificity and efficiency of in vivo adenine base editing therapies with hybrid guide RNAs

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.22.590531

N/A

0.208DataRank · unranked

3 citations

Lauren C. Testa, Dominique L. Brooks, Aidan Quigley, Hooda Said, Garima Dwivedi +12 more

Epigenome Editing Durability Varies Widely Across Cardiovascular Disease Target Genes

Arteriosclerosis Thrombosis and Vascular Biology(2023)10.1161/atvbaha.123.319748

N/A

0DataRank · unranked

16 citations

Lauren Testa, Aidan Quigley, Ishaan Jindal, Saúl V. Cortez-Alvarado, Ping Qü +5 more

Epigenome Editing Durability Varies Widely Across Cardiovascular Disease Target Genes

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.17.541156

N/A

0DataRank · unranked

2 citations

Lauren Testa, Aidan Quigley, Ishaan Jindal, Saúl V. Cortez-Alvarado, Ping Qü +5 more

Improved specificity and efficiency of in vivo adenine base editing therapies with hybrid guide RNAs

Nature Biomedical Engineering(2025)10.1038/s41551-025-01545-y

N/A

0DataRank · unranked

9 citations

Lauren Testa, Aidan Quigley, Dominique L. Brooks, Sarah Grandinette, Hooda Said +14 more

Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo

Research Square(2022)10.21203/rs.3.rs-1836399/v1

N/A

0DataRank · unranked

0 citations

Yong Tao, Yiran Li, Wan Du, Madelynn N. Whittaker, John A. Zuris +13 more

Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo

Nature Communications(2023)10.1038/s41467-023-40476-7

N/A

0DataRank · unranked

48 citations

Verónica Lamas, Wan Du, Wenliang Zhu, Yiran Li, Madelynn N. Whittaker +14 more

A base editing strategy using mRNA-LNPs for in vivo correction of the most frequent phenylketonuria variant

Human Genetics and Genomics Advances(2023)10.1016/j.xhgg.2023.100253

N/A

0DataRank · unranked

24 citations

Madelynn N. Whittaker, Hooda Said, Garima Dwivedi, Ping Qü, Kiran Musunuru +4 more